Vitamin D3
VesperLynd
13 Sep 2011
Is it possible or not harmful to take twice the usual dosage until levels begin to show improvement?
Thank you, VL
jep
13 Sep 2011
Just to maintain my levels (around 60-65 ng/ml), I need to take 4000-5000 IU most days. To get my levels from where they were (<10 ng/ml), I had to take 20,000 IU daily for 2 weeks, then 10,000 IU daily for another 2 weeks).
pycnogenol
13 Sep 2011
How much vitamin D3 are you currently taking? I take 7,500 IU daily and I'm at 50 ng/ml.
hippocampus
13 Sep 2011
DbCooper
14 Sep 2011
I would recommend you to take recommended dosage (100-200% RDA), then do some blood tests and if situation doesn't improve, talk to your doctor. I'm skeptical about taking very high dosage for a very long time for any supplement, because numeruous studies of different vitamins (A, E, beta-carotene, follic acid) have shown this is not good.
Just out of curiosity what are your 25 Hydroxy levels, I see your advice as potentially life threatening in the long run. 400-800 IU of Vitamin D will not do anything to anyone.
niner
14 Sep 2011
hallucinogen
14 Sep 2011
Science behind vitamin D
A number of studies have suggested that patients with chronic inflammatory diseases are deficient in 25-hydroxyvitamin D (25-D) and that consuming greater quantities of vitamin D, which further elevates 25-D levels, alleviates disease symptoms.
Some years ago, molecular biology identified 25-D as a secosteroid. Secosteroids would typically be expected to depress inflammation, which is in line with the reports of short-term symptomatic improvement. The simplistic first-order mass-action model used to guide the early vitamin studies is now giving way to a more complex description of action.
When active, the Vitamin D nuclear receptor (VDR) affects transcription of at least 913 genes and impacts processes ranging from calcium metabolism to expression of keyantimicrobial peptides. Additionally, recent research on the Human Microbiome shows that bacteria are far more pervasive than previously thought, dramatically increasing the possibility that the spectrum of chronic diseases is bacterial in origin.
Emerging molecular evidence suggests that symptomatic improvements among those administered vitamin D is the result of 25-D’s ability to temper bacterial-induced inflammation by slowing VDR activity. While this results in short-term palliation, persistent pathogens that influence disease progression proliferate over the long-term.
Forms and structure of vitamin D
All forms of vitamin D are secosteroids, sharing a close structural and functional resemblance to steroids. The full implications of a “vitamin” acting as a steroid has yet to be fully appreciated by many in the research community. The overlap between steroids and secosteroids is key to understanding the Marshall Pathogenesis. It explains how a “vitamin” can exert short-term palliative effects and long-term harm. Patients on the MP are advised to avoid consuming vitamin D, because of its immunomodulatory effects.
Steps for synthesis of Vitamin D
There are a number of vitamin D metabolites in the body. The steps by which one form of vitamin D changes into the next are as follows:
The body has natural stores of 7-dehydrocholesterol, a cholesterol precursor.
When exposed to energy, specifically ultraviolet light, 7-dehydrocholesterol becomes pre-vitamin D3.
Pre-vitamin D3 spontaneously isomerizes to Vitamin D3 via a process called sigmatropic shift.
In addition to the endogenous production of Vitamin D3, people get D3 from animal meats. Vitamin D2 is found in plants and fungi, and is functionally similar to D3.
Vitamin D3 and D2 are hydroxylated in the liver, and becomes 25-hydroxyvitamin D (25-D).
25-D is further hydroxylated by the enzyme 1α-hydroxylase, into the main biologically active hormone 1,25-dihydroxyvitamin D(1,25-D). While this reaction was originally thought to occur only in the kidneys, is now known to take place in tissues throughout the body, including within white blood cells called macrophages.

Metabolism of vitamin D and the Vitamin D Receptor
A number of studies have suggested that patients with chronic inflammatory diseases are deficient in 25-hydroxyvitamin-D (25-D) and that consuming greater quantities of vitamin D, which elevates 25-D levels, alleviates symptoms of disease. Some years ago, molecular biology identified 25-D as a secosteroid. Secosteroids would typically be expected to depressinflammation, which is in line with the reports of symptomatic improvement. The simplistic first-order mass-action model used to guide the early vitamin studies has given way to a more complex description of action. When active, the Vitamin D nuclear receptor (VDR) affects transcription of at least 913 genes and impacts processes ranging from calcium metabolism to expression of key antimicrobial peptides.
Located in the nucleus of a variety of cells including immune cells, the VDR is a control system of sorts. When exposed to infection and damage, especially that which is caused by pathogens, the body begins to convert the inactive form 25-D into the active form, 1,25-D. As cellular concentrations of 1,25-D increase, 1,25-D activates the VDR, turning on any number of genes the receptor transcribes.
According to a 2010 analysis, the VDR significantly affects 229 human genes. Many of these genes have long been associated with autoimmune diseases and cancers including, for example, the genes IRF8 (linked to multiple sclerosis), and PTPN2 (connected to Crohn's disease and type I diabetes).1 The activation of certain genes also leads to the synthesis of antimicrobial peptides. The antimicrobial peptides are the body's “natural antibiotics” and have a potent anti-bacterial effect.
However, bacteria create ligands, which like 25-D, inactivate the VDR and, in turn, the innate immune response. This allows the microbes to proliferate. In response, the body increases production of 1,25-D from 25-D, leading to one of the hallmarks of chronic inflammatory disease: a low 25-D and a high 1,25-D.
This pattern is a result of the disease process rather than a cause. For a variety of reasons, neither increased consumption of vitamin D nor the body's synthesis of additional 1,25-D is ultimately effective at combatting infection.
Supplemental Vitamin D tends to be immunosuppressive
Supplemental vitamin D has been widely lauded for conferring immunosuppressive effects.
Vitamin D affects the immune system at many levels and by a number of mechanisms…. Vitamin D has multiple immunosuppressant properties…. On the whole, vitamin D confers an immunosuppressive effect.
Aronson, Amital, and Shoenfeld 2
Examples of vitamin D's immunosuppressant effects include:
Epstein Barr virus – In a 2010 study of pregnancy-associated breast cancer, higher levels of 25-D were positively correlated with serum antibodies to Epstein Barr Virus, suggesting that EBV is able to better proliferate in patients who take vitamin D.3toll-like receptors – As discussed elsewhere, the toll-like receptors (TLR) represent an ancient front-line defense system that enables the host organism to sense the presence of microbial components within minutes. As inducers of inflammation, TLRs act as important triggers of distinct entities such as sepsis or autoimmune disease exacerbation.4 For example, found that the TLRs are naturally upregulated in the autoimmune disease, Behcet's disease.5 However, a 2006 study showed that vitamin D3 suppresses the expression of TLR2 and TLR4 protein and mRNA in human monocytes in a time- and dose-dependent fashion.6Dickie et al. further showed that expression of TLR9 was downregulated in monocytes by vitamin D3 supplementation.7
short-term symptom resolution – Further evidence for vitamin D’s activity as an immunosuppressant comes in the range of reports of short-term symptom resolution in autoimmune patients taking vitamin D. Online forums are full of such reports.
Role in select diseases and conditions
The following articles discuss the role of vitamin D in select diseases. A more complete list of diseases that have been shown to have low level of 25-D is also available.
Osteoporosis
Both osteoporosis and osteopenia are diseases marked by a decrease in bone mineral density. Osteopenia is a less severe form of and sometimes precursor to osteoporosis. The loss of bone mass leads to a porous bone structure, frequent fractures, and delayed healing.
Among doctors, and even many researchers, it is conventional wisdom that vitamin D supplementation reverses osteopenia and osteoporosis. However, a growing body of interventional trials and molecular evidence shows this is not the case. Instead, current research has demonstrated that osteoporosis and osteopenia are often the direct result of infection with the Th1 pathogens, ametagenomic microbiota, which produce inflammatory cytokines and inactivate the Vitamin D Receptor. The only way to achieve long-term reversal of bone loss is to kill the Th1 pathogens driving the disease process.
Rickets
Rickets (osteomalacia) is a softening of the bones that leads to fractures and deformity. The majority of cases of rickets occur among children in developing countries who suffer from severe malnutrition. The disease is cited as a primary reason for consuming vitamin D regularly even though research has demonstrated that rickets is not caused by vitamin D deficiency but by hypophosphatemia.
The latest molecular evidence does not support adding high levels of vitamin D to the food chain in the name of “preventing rickets.” The health of the public would be much better served by regulations ensuring that they obtain adequate calcium and phosphorous rather than vitamin D.
Cancer
A variety of studies have suggested that vitamin D protects against cancer. This seemingly intuitive proposition is supported by neither epidemiological nor molecular evidence. In fact, the very opposite is true. This article reviews why this body of research is most likely incorrect – or at the very least, much more complicated than articles in the popular media would have a person believe.
Latitude studies - The “latitude studies” are observational, as opposed to interventional, studies, which use ambient solar UV radiation as a proxy for latitude and vitamin D status. For these studies, researchers compare rates of certain major cancers - most notably breast, colorectal and prostate cancer - to rates of sunlight exposure. This group of research has the liability of being wildly inconsistent. The choice to publish research on a specific latitude gradient may be a better proxy for a researcher's bias.
Interventional studies - While some randomized controlled trials have suggested that consuming vitamin D reduces rates of cancer, larger and more carefully controlled studies show no such effect.
Studies of vitamin D status - Many of the studies examining the relationship between vitamin D status and incidence of cancer argue that low levels of 25-D contribute to cancer. This conclusion has been invalidated by larger well-controlled studies. Although the immune system works to downregulate 25-D (25-hydroxyvitamin D) in inflammatory diseases such as cancer, very high levels of 25-D are a clear indication of regular supplementation. These studies suggest that consuming large amounts of vitamin D predispose a person to increased incidence of cancer.
Observational studies – Some case control studies have found that vitamin D intake seems to increase incidence of certain types of cancer.
Cardiovascular disease
According to a 2010 paper by Swales and Wang, “despite substantial clinical evidence linking vitamin D deficiency with increased cardiovascular risk, it remains to be established whether this represents a causal association.”8
A recent cross-sectional study involving 340 African Americans with type 2 diabetes found that serum 25-hydroxyvitamin D levels were positively associated with increased calcified atherosclerotic plaque in the aorta and carotid arteries.9
Depression and seasonal affective disorder
According to the Marshall Pathogenesis, light-related changes in mood can be attributed to fluctuations in 1,25-dihydroxyvitamin D (1,25-D). Such reactions exist in people who suffer from “seasonal affective disorder” as well as those who are addicted to or dependent upon tanning.
Contrary to popular belief, epidemiological research points to an increase in suicide across countries during the beginning of the summer months when people tend to get more light exposure.
Light exposure does nothing to resolve underlying disease state and can actually delay progress for Marshall Protocol (MP) patients. Certainly prolonged light exposure has been shown to increase skin melanoma – the World Health Organization now categorizes tanning beds under the highest cancer risk category.10
MP patients who have completed the treatment have been able to attest to the fact that sunshine is not necessary for good health or happiness.
Despite what some researchers have argued, latitude studies that try to tie ambient solar UV radiation to prevalence of disease have been inconclusive.
Pregnancy
1,25-D rises by 40% in the early pregnant decidua, meaning that its ability to dysregulate the nuclear receptors and the antimicrobial peptides (AmPs) they express is particularly prevalent during the first trimesters of pregnancy. The subsequent decrease in immune function slows immunopathology, resulting in symptomatic relief. But when the surge in 1,25-D disappears after pregnancy, AmP expression and immunopathology increase once again, leading to exacerbation of disease symptoms. This may explain why some women with autoimmune disease experience periods of palliation during gestation only to become increasingly symptomatic after giving birth.
Problems with some Vitamin-D Research...
Insufficient followup in vitamin D studies
One of the abiding weaknesses of studies on the effects of vitamin D on health is that researchers simply do not follow subjects consuming the secosteroid for a sufficient period of time. Instead, they tend to track subjects over the course of weeks, months, or one or two years, during the period of time when study participants are usually feeling the palliative effects of the steroid. This practice is a mistake as it does not account for the long-term immunosuppressive effects of a steroid.
Falling to control for biases inherent to observational studies
It is arguably impossible to sufficiently control for the socioeconomic factors, which drive a person to participate in a therapy or take a supplement. The case of hormone replacement therapy (HRT) is instructive. For decades, researchers thought that HRT prevented disease, but it was ultimately shown that it caused it.
Studies of vitamin D's efficacy are especially fraught with challenges. For one, the secosteroid is palliative and the negative side effects can only be seen after decades of use. Also, people who take vitamin D are demonstrably different than those who don't. They almost always have a higher socioeconomic status.
Not all studies on vitamin D's efficacy are observational, but those that are may warrant a special amount of skepticism.
Mistaking correlation for causation
Many vitamin D studies suffer from methodological errors including bias inherent to using self-selected subjects and insufficient followup, but perhaps their most egregious liability comes in mistaking correlation for causation.
It's undisputed that a wide array of studies point to the fact that 25-hydroxyvitamin D (25-D) – typically referred to in the media as vitamin D – is low in people with numerous chronic inflammatory diseases. However, these studies fail to prove that low 25-Dcauses disease.
In fact, molecular science has revealed that the levels of the vitamin D metabolites through a series of intricate and carefully controlled feedback pathways, mechanisms that belie the simplistic first-order mass-action model used to guide the short-sighted vitamin studies. Also, epidemiological evidence suggests that while 25-D is low in chronic disease, 1,25-D (1,25-dihydroxyvitamin D) tends to be very high, an observation which is at odds with the theory that vitamin D deficiency causes or exacerbates disease.
There have been lots of observational studied showing an association between various diseases and vitamin D deficiency, but there is not any evidence yet that that is a casual relationship… it may be that vitamin D deficiency is a marker of ill health.
Dr. Ruth McQuillan, University of Edinburgh
Populations that avoid vitamin D remain healthy despite low levels of 25-D
According to Professor Roger Bouillon of the University of Leuven, “over one billion” people worldwide need to increase their vitamin D intake due to vitamin D “deficiency.”11 One Saudi study concluded that 87.8% of healthy men were “deficient.”
Yet, observational studies show that populations which avoid vitamin D consumption have naturally low levels of 25-D and remain healthy with such levels.
healthy Chilean women – A study which tested the level of 25-D in 90 “healthy, ambulatory Chilean women” showed that 27% of the premenopausal and 60% of the postmenopausal women had 25-D levels under 20 ng/ml.12
healthy Bangladeshi women – A study on healthy Bangladeshi women found that approximately 80% of the women had a level of 25-D under 16 ng/ml.13
healthy Chinese infants – In a 1992 study, healthy full-term infants from China had serum concentrations of 25-D ranging from an average of 5 ng/ml to 14 ng/ml.14
healthy Omani women – A 2011 study of 41 apparently healthy women (ages 18-45 years) working at the Royal Hospital, Muscat, Oman found that all study subjects had 25-D levels below 50 nmol/L.15
young healthy adults in western India – Among young healthy adults from the western part of India, the average serum level of 25-D indicated vitamin D “deficiency”: 17.4 ng/ml.16
healthy Saudi Arabians – Severe hypovitaminosis D is widespread and more common in non-diabetics than diabetics in Saudi adults.17Nevertheless, this 2010 study's authors conclude a bit bizarrely, “The study further underscores the need for vitamin D fortification of the Saudi diet, and the promotion of vitamin D supplementation in both groups.”
healthy lactating mothers – Even when lactating mothers take all but exceedingly high levels of vitamin D – 6,000 IU which is 15 times the United States' Recommended Daily Intake – the vitamin D content in breast milk remains very low.18 This is confusing for advocates of vitamin D supplementation who would think that breastfeeding mothers would give their infantextra levels of vitamin D during formative stages of growth.
One of the great mysteries in human biology is the fact that most human breast milk is deficient in vitamin D. How could Nature overlook such an important nutrient in the “perfect food”?
Vitamin D Council
The patients all wore protective clothing and sunscreens when outdoors. Estimated mean vitamin D intake was normal. The mean values of serum 25-OHD were low normal, but 1,25-(OH)2D, calcium, ionized calcium and parathyroid hormone levels were normal[italics added]…. Despite rigorous sun protection normal vitamin D levels can be maintained in ambulatory patients with XP.
Armando Sallitto et al.19
Ramifications of a simplistic understanding of vitamin D metabolism
Numerous studies have identified patient populations that are “deficient” in vitamin D. Patients suffering from obesity,schizophrenia, fibromyalgia, multiple sclerosis, autism, etc. all seem to be suffering from vitamin D deficiency. One could listhundreds of such studies.
Although it is not unheard of, few seem to explore the possibility that a low 25-D is the result of disease. Perhaps it is because researchers conceptualize vitamin D as they might a resource which gets used up and needs to be replenished – not unlike gasoline when a car runs low. This metaphor is not at all apt, because vitamin D is regulated like the steroid it is.20 21
Large segments of the population are consuming vitamin D at historic levels. Like the first-line treatment for many autoimmune diagnoses, the corticosteroid Prednisone, vitamin D temporarily reduces symptoms of disease, but long-term use dramatically increases the odds of disease relapse.22
In practice, widespread and systematic supplementation of vitamin D may serve to drive a kind of self-fulfilling prophesy. When whole populations are given large amounts of vitamin D, the only members of that population who remain “deficient” are those whose immune systems are fighting disease by actively downregulating 25-D. In other words, the more rigorously vitamin D is added to milk, juice, snack bars, and breakfast cereals, the less likely it is that someone has low levels of vitamin D but no chronic disease.
Supplemental vitamin D given to healthy people
According to the Marshall Pathogenesis, limited amounts of vitamin D may be helpful for a time to healthy people. Because the body is able to properly regulate the VDR, ingested vitamin D is rapidly converted into 1,25-D, which activates the VDR. This may explain the one (barely) significant finding from a 2011 Cochrane systematic review.23 (Publication bias may have also tilted the findings towards intervention.) However, this is certainly no basis for forced fortification.
Marshall Protocol and vitamin D
As opposed to certain treatments which employ sunshine or light therapy, patients on the Marshall Protocol (MP) use the VDR agonist, olmesartan, and pulsed, low-dose antibiotics to gradually eliminate the Th1 pathogens. Patients on the treatment must refrain from supplementing with vitamin D or eating any foods that contain vitamin D. These measures allow 25-D levels to drop to a point where the VDR can most optimally activate the innate immune system.
Because the vitamin D metabolites are dysregulated in chronic disease, most patients on the MP also become sensitive to light. Although light sensitivity improves as the Th1 pathogens are killed, most patients must avoid bright sunlight and block bright light in the eyes with special sunglasses during the healing process. However, once the Th1 pathogens have been killed and the vitamin D metabolites have re-stabilized, patients are able to tolerate sunlight and bright lights once again.
References
1. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton SM, Watson CT, Morahan JM, Giovannoni G, Ponting CP, Ebers GC, Knight JC A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010;20:1352-60.
2. Arnson Y, Amital H, Shoenfeld Y Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66:1137-42.
3. Agborsangaya CB, Lehtinen T, Toriola AT, Pukkala E, Surcel HM, Tedeschi R, Lehtinen M Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: Joint effect with vitamin D? Eur J Cancer. 2010;:.
4. , 6. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zügel U, Steinmeyer A, Pollak A, Roth E, Boltz-Nitulescu G, Spittler A Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006;36:361-70.
5. Do JE, Kwon SY, Park S, Lee ES Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology (Oxford). 2008;47:840-8.
7. Dickie LJ, Church LD, Coulthard LR, Mathews RJ, Emery P, McDermott MF Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes. Rheumatology (Oxford).2010;49:1466-71.
8. Swales HH, Wang TJ Vitamin D and cardiovascular disease risk: emerging evidence. Curr Opin Cardiol. 2010;22:513-7.
9. Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC, Gordon EJ, Xu J, Langefeld CD, Divers JVitamin d, adiposity, and calcified atherosclerotic plaque in african-americans. J Clin Endocrinol Metab. 2010;95:1076-83.
10. El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V A review of human carcinogens--part D: radiation. Lancet Oncol. 2009;10:751-2.
11. Boullion, R. (2006 April 2). Vitamin D analogues: pharmacology and therapeutic uses. European Congress of Endocrinology, Glasgow.
12. González G, Alvarado JN, Rojas A, Navarrete C, Velásquez CG, Arteaga E High prevalence of vitamin D deficiency in Chilean healthy postmenopausal women with normal sun exposure: additional evidence for a worldwide concern. Menopause.2007;14:455-61.
13. Islam MZ, Akhtaruzzaman M, Lamberg-Allardt C Hypovitaminosis D is common in both veiled and nonveiled Bangladeshi women. Asia Pac J Clin Nutr. 2006;15:81-7.
14. Specker BL, Ho ML, Oestreich A, Yin TA, Shui QM, Chen XC, Tsang RC Prospective study of vitamin D supplementation and rickets in China. J Pediatr. 1992;120:733-9.
15. Al-Kindi MK Vitamin D Status in Healthy Omani Women of Childbearing Age: Study of female staff at the Royal Hospital, Muscat, Oman. Sultan Qaboos Univ Med J. 2011;11:56-61.
16. Shivane VK, Sarathi V, Bandgar T, Menon P, Shah NS High prevalence of hypovitaminosis D in young healthy adults from the western part of India. Postgrad Med J. 2011;:.
17. Al-Daghri NM, Al-Attas OS, Al-Okail MS, Alkharfy KM, Al-Yousef MA, Nadhrah HM, Sabico SB, Chrousos GP Severe hypovitaminosis D is widespread and more common in non-diabetics than diabetics in Saudi adults. Saudi Med J. 2010;31:775-80.
18. Wagner CL, Hulsey TC, Fanning D, Ebeling M, Hollis BW High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med. 2006;1:59-70.
19. Sollitto RB, Kraemer KH, DiGiovanna JJ Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum. J Am Acad Dermatol. 1997;37:942-7.
20. Moan J, Lagunova Z, Lindberg FA, Porojnicu AC Seasonal variation of 1,25-dihydroxyvitamin D and its association with body mass index and age. J Steroid Biochem Mol Biol. 2009;113:217-21.
21. Schwartz JB Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence. Clin Pharmacol Ther. 2009;85:198-203.
22. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest. 1997;111:623-31.
23. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;7:CD007470.
24. Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr. 2000;72:472-5.
25. Crew KD, Shane E, Cremers S, McMahon DJ, Irani D, Hershman DL High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol. 2009;27:2151-6.
26. Wjst M Introduction of oral vitamin D supplementation and the rise of the allergy pandemic. Allergy Asthma Clin Immunol.2009;5:8.
Edited by hallucinogen, 14 September 2011 - 06:47 AM.
jep
15 Sep 2011
Do you have anything positive to say about any supplement? You seem to be against practically everything.
Denjin
16 Sep 2011
Also, for me to actually create enough D on my own I'd have to expose my entire body to the sun for 15 minutes a day since I'm a redhead. I don't really plan on full-nudity sun-bathing with no sunscreen. :p
niner
16 Sep 2011
pycnogenol
16 Sep 2011
Brainbox
17 Sep 2011
http://www.ncbi.nlm....les/PMC2678245/
This review more or less states that D enhances the innate immune system to fight bacteria and modulates (or decreases?) the adaptive Immune system to decrease long term inflammation for instance in the case of chronic or auto immune issues.
Could it be possible that the controversy in our understanding of D effects is caused by this dual sword action?
Edited by Brainbox, 17 September 2011 - 09:35 AM.
Brainbox
17 Sep 2011
So, for D and in general, the statistical approach to healthcare is reaching it's limitations?
And, concentrating on only one or two D metabolites poses such a severe limitation in our understanding that we can only beat around the bush a bit, but cannot come to any ground breaking insight?
Well, we have to start somewhere to gain knowledge I guess, but it seems very hard to not run around in circles without obtaining any real progress.....
niner
17 Sep 2011
Could it be possible that the controversy in our understanding of D effects is caused by this dual sword action?
What controversy? The word 'controversy' carries an implication that science is divided on an issue. I'm not sure that this case rises to that standard.
Brainbox
17 Sep 2011
But my current position towards D is to be careful, even more conservative as compared to you. I did not read all the D studies, but quite a lot. Apart from a lot of details I do not yet fully know and comprehend, I still see a slight confirmation of the suppressive effect of D on the so called adaptive immune response and the short term relieve of symptoms Marshall refers to. My understanding (in one sentence and hence abbreviated and certainly in layman's terms) is that I cannot tell what the net effect would be of the initial increasing effect on the innate immune response, the modulating (decreasing) effect on the adaptive response and possible feed-back loops that could turn the positive effect on the innate repose towards something less positive because down-regulation of the adaptive response.
This is the controversy I perceive, not only from Marshall's protocol, but also reading and interpreting individual study results that address this matter.
Caution is my middle name regarding these issues since I already have one minor chronic issue that I don't want to exaggerate.
Edited by Brainbox, 17 September 2011 - 04:50 PM.
Al-Iksir
08 Nov 2011
Your intake isn´t that important, your serum level is. You can take 50k IU/day, as long as you stay below about 120ng/ml.I need to increase my Vitamin D levels since they are low <25.
Is it possible or not harmful to take twice the usual dosage until levels begin to show improvement?
Thank you, VL
You should take some vitamin K with it tough.
birthdaysuit
05 Jun 2016
AVOiD All Vitamin D Supplementation ...
Science behind vitamin D
A number of studies have suggested that patients with chronic inflammatory diseases are deficient in 25-hydroxyvitamin D (25-D) and that consuming greater quantities of vitamin D, which further elevates 25-D levels, alleviates disease symptoms.
Some years ago, molecular biology identified 25-D as a secosteroid. Secosteroids would typically be expected to depress inflammation, which is in line with the reports of short-term symptomatic improvement. The simplistic first-order mass-action model used to guide the early vitamin studies is now giving way to a more complex description of action.
When active, the Vitamin D nuclear receptor (VDR) affects transcription of at least 913 genes and impacts processes ranging from calcium metabolism to expression of keyantimicrobial peptides. Additionally, recent research on the Human Microbiome shows that bacteria are far more pervasive than previously thought, dramatically increasing the possibility that the spectrum of chronic diseases is bacterial in origin.
Emerging molecular evidence suggests that symptomatic improvements among those administered vitamin D is the result of 25-D’s ability to temper bacterial-induced inflammation by slowing VDR activity. While this results in short-term palliation, persistent pathogens that influence disease progression proliferate over the long-term.
This happened to me with Lyme disease. I started taking Vitamin D3 in high dosages with creatine and felt amazing. When I stopped I relapsed and had a 105 degree fever with severe joint pain.
For most Lyme sufferers I would think abstaining from all Vitamin D3 is a bad idea. The Marshall protocol certainly advocates this and I think it will do more harm than good by suppressing the immune system.
Elusive
14 Sep 2016
Has anybody experienced diminishing of libido (that raging desire to have sex) with chronic intake of D3?
My erection is fine (and i guess D3 improves testosterone levels as well) but desire gets partially blunted and I also cant hold my sprinklers from going off for very long, while on D3.
I have tried it on and off and somehow all other parameters of sex (like erection, orgasm, ejaculation is fine)...its just the over all intense pleasure of sex or intensity and satisfaction afterwards is diminished. (I have used 1000 - 2000 iu/day)
Can any one comment on why it may be happening with D3? Thanx.
pamojja
14 Sep 2016
(I have used 1000 - 2000 iu/day)
Can any one comment on why it may be happening with D3? Thanx.
With that little intake my serum levels would be clearly deficient. What is your 25(OH)D3 serum level?
pamojja
14 Sep 2016
Igot it checked recently and it was 78 nmol/L which is adequate.
Though every labs normal reference range is a bid different, if I convert it to 31 ng/ml with my labs normal range of 30-100 - you're at the lowest end of normal.
And you seriously hypothesis that a daily dose which barely got you out of deficiency could have been detrimental to your libido?
http://www.ewg.org/r...deficiencies-us
Nutrient from food alone, ranked by the occurrence of dietary inadequacy among adults | Percentage of dietary intakes below the estimated average requirement for a specific population* | Naturally occurring sources of nutrient** |
2-to-8-year-old children | 14-to-18-year-old girls | Adults 19 and older
Vitamin D | 81% | 98% | 95% | Fatty fish, mushrooms [vitamin D is naturally formed in the body when skin is exposed to sunlight; vitamin D is added to fortified milk]
Vitamin E | 65% | 99% | 94% | Nuts, seeds, vegetable oils, green leafy vegetables
Magnesium | 2% | 90% | 61% | Whole grains, wheat bran and wheat germ, green leafy vegetables, legumes, nuts, seeds
Vitamin A | 6% | 57% | 51% | Preformed vitamin A: liver, fatty fish, milk, eggs; provitamin A carotenoids: carrots, pumpkins, tomatoes, leafy green vegetables
Calcium | 23% | 81% | 49% | Milk, yogurt, cheese, kale, broccoli
Vitamin C | 2% | 45% | 43% | All fruits and vegetables, particularly citrus fruits and tomatoes
Vitamin B6 | 0.1% | 18% | 15% | Many foods; highest levels in fish, beef, poultry, potatoes and other starchy vegetables, and fruit other than citrus
Folate | 0.2% | 19% | 13% | Many foods; highest levels in spinach, liver, asparagus, Brussels sprouts [mandatory, standardized addition to enriched flour and flour products]
Zinc | 0.2% | 24% | 12% | Red meat, poultry, beans, nuts, some seafood, whole grains
Iron | 0.7% | 12% | 8% | Highest amounts in meat and seafood; lower levels in nuts and beans [mandatory, standardized addition to enriched flour and flour products]
Thiamin | 0.1% | 10% | 7% | Whole grain products [mandatory, standardized addition to enriched flour and flour products]
Copper | 0% | 16% | 5% | Shellfish, whole grains, beans, nuts, potatoes, organ meats (kidneys, liver)
Vitamin B12 | 0% | 7% | 4% | Animal products: fish, meat, poultry, eggs, milk
Riboflavin | 0% | 5% | 2% | Milk and dairy products, eggs, meat, green leafy vegetables, legumes [mandatory, standardized addition to enriched flour and flour products]
Niacin | 0.1% | 4% | 2% | Meat, fish, seeds and nuts, whole grains [mandatory, standardized addition to enriched flour and flour products]
Selenium | 0% | 2% | 1% | Found in different plant and animal foods; highest levels in seafood and organ meats (kidneys, liver)
I rather suspect a combination of nutritional deficiencies, certain lifestyle factors, diet and stress at the root of your difficulties. What is your age?
Edited by pamojja, 14 September 2016 - 07:43 PM.
Elusive
14 Sep 2016
I understand that... What I am asking is that why I have repeatedly experienced the diminishing of libido with D3?
By the way if I stop taking D3, my libido comes back to normal after 2 to 3 days. Has anyone else experienced this kind of phenomenon?
2000 iu should take me through the roof (sex-wise) as I am on the lower end of normal but NOTdeficient at all.
Should I try ginkgo with it to defeat this loss or start taking a multivitamin?
What should I do?
Because I seriously like the intelligence boosting effects of D3 as it speeds up the information processing and comprehension of my brain 10 folds! (specially at 2000iu dose at breakfast).
Somebody please figure this out, it would be a great help.
Elusive
14 Sep 2016
Ok... i think my serotonin synthesis increases and that suppresses the libido.
I have experienced similar effects with fish oil but not to that extent so i dont take fish oil regularly. Please check this link out....
http://www.ncbi.nlm....pubmed/25713056
What should I do about it?
pamojja
14 Sep 2016
I rather suspect a combination of nutritional deficiencies, certain lifestyle factors, diet and stress at the root of your difficulties. What is your age?
I understand that...
By the way if I stop taking D3, my libido comes back to normal after 2 to 3 days. Has anyone else experienced this kind of phenomenon?
2000 iu should take me through the roof (sex-wise) as I am on the lower end of normal but NOTdeficient at all.
Should I try ginkgo with it to defeat this loss or start taking a multivitamin?
What should I do?
The only reason I can come up with is again, you have a number of nutritional deficiencies beside other things going on. Upping only D3, of course, will deplete codependent nutrients even further. D3 depends for example on Magnesium, Vitamin A, K2 etc.
If you're rich you could have your other nutrient levels tested. Otherwise start with a comprehensive Multi, like 1 capsule of Lef's Two-per-day, extra Magnesium, Fish oil, K vitamins, B vitamins (without folic acid), etc.
pamojja
14 Sep 2016
Ok... i think my serotonin synthesis increases and that suppresses the libido.
I have experienced similar effects with fish oil but not to that extent so i dont take fish oil regularly. Please check this link out....
http://www.ncbi.nlm....pubmed/25713056
What should I do about it?
We propose a model whereby insufficient levels of vitamin D, EPA, or DHA, in combination with genetic factors and at key periods during development, would lead to dysfunctional serotonin activation and function and may be one underlying mechanism that contributes to neuropsychiatric disorders and depression.
Don't read anything into studies which isn't there to begin with.
Nate-2004
18 Sep 2016
I have Essential Tremor, which is a kinetic or action based tremor (in my case the hands), non parkinson tremor that has a terrible impact on my quality of life, especially socially. I love video games but it makes me suck at them, and don't even get me started on performing improv comedy on stage, dating, playing the piano and stuff like that. So far there is no cure but that's because all the focus is on Parkinson's and there is very little if any research going on, despite that it affects 10x the number of people as Parkinson's.
The one supplement that has had any impact whatsoever on the tremor, is vitamin D3. Its effects are comparable to a high dose of propanolol, the only prescription medication that has an effect on it but with terrible side effects. Unfortunately the effect doesn't last longer than a week before its benefits begin to fade. So I stop taking it for a while, and then when I take it again the next time after a month or two, I get that same effect for a week.
I don't know what D3 has to do with ET, but it's related, much like serotonin, noradrenaline and gaba are somewhat related to it as well. Serotonin and noradrenaline quite negatively affect the tremor. It's why the tremor is so bad after a work out or after taking any stimulant.
I have a thread of things I've tried on Reddit, if anyone with ET wants to also try D3 in high doses (3000 - 6000 IU), give it a try and let me know what happens after a couple of weeks.
Because of the neurologist shortage in America, I have to wait months for an appointment but I have one in October, when I will finally look into botox and high frequency ultrasound as treatment options.